Perceptive Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-307,021
Closed -$20.4M 123
2019
Q2
$20.4M Sell
307,021
-187,979
-38% -$11M 0.47% 48
2019
Q1
$27.5M Buy
495,000
+435,000
+725% +$26.6M 0.78% 34
2018
Q4
$2.97M Buy
+60,000
New +$3.67M 0.11% 71
2018
Q3
Sell
-195,000
Closed -$11.3M 131
2018
Q2
$11.3M Sell
195,000
-325,000
-63% -$15.9M 0.3% 57
2018
Q1
$21M Buy
+520,000
New +$19.6M 0.59% 42
2017
Q4
Sell
-14,641
Closed -$485K 151
2017
Q3
$485K Buy
+14,641
New +$480K 0.02% 124
2016
Q4
Sell
-15,000
Closed -$275K 211
2016
Q3
$275K Buy
+15,000
New +$263K 0.02% 154

Other funds holding TDOC

Perceptive Advisors's TDOC Position: Q3 2019 in Review

Perceptive Advisors sold out of Teladoc Health (TDOC) in Q3 2019, closing a stake of 307,021 shares — an estimated $20.4M sold.

Perceptive Advisors first reported a position in TDOC in Q3 2016 and held it in 7 quarters. The position peaked at $27.5M in Q1 2019. 378 funds tracked by Wall St. Rank hold TDOC as of Q3 2019.

  • Perceptive Advisors reported no remaining Teladoc Health position as of Q3 2019 after selling out during the quarter.
  • Perceptive Advisors sold 307,021 Teladoc Health shares in Q3 2019, an estimated $20.4M.
  • Perceptive Advisors first reported a position in Teladoc Health in Q3 2016 and held it in 7 quarters.
  • Perceptive Advisors's Teladoc Health position peaked at $27.5M in Q1 2019.
  • 378 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2019.

Based on Perceptive Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.